Translate this page into:
Pulmonary hot-clot artifacts mimicking as metastatic lung lesions in 18F-fluorodeoxyglucose positron emission tomography/computed tomography – A case series
*Corresponding author: Sibhithran Rajakumar, Department of Radio-diagnosis, A.C.S. Medical College and Hospital, Chennai, Tamil Nadu, India. sibhius@gmail.com
-
Received: ,
Accepted: ,
How to cite this article: Rajakumar S, Murali A, Periakaruppan G, Rangasami R. Pulmonary hot-clot artifacts mimicking as metastatic lung lesions in 18F-fluorodeoxyglucose positron emission tomography/computed tomography – A case series. Case Rep Clin Radiol 2023;1:5-9.
Abstract
Significant rise in oncological patients everyday led to demand for 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) scan for tumor staging, evaluation of treatment response, and monitoring/management which have become a standard of care. Basic knowledge on the physiological tracer uptakes, normal variants, and benign processes in PET/CT will help in differentiating hotclot/pulmonary microemboli artifacts from metastasis in lungs. We have encountered four such cases at our setup with different clinical history and would like to discuss on its importance in reporting and not to overcall it as lung metastasis.
Keywords
FDG PET/CT
FDG PET/CT Artifacts
FDG PET/CT Pitfall
Hot emboli
Hotclot artifact
Microembolism
False positive
INTRODUCTION
18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) scan has come to widespread use for various indications in everyday clinical practice for methodical assessment and channelized treatment according to the characterization and stage of the lesion. As PET/CT plays a key role in oncological evaluation of a patient, accurate scanning and interpretation are crucial. An artifact is a substance or structure that was not present originally in the object and is seen in the image being taken by any modality.[1] Artifacts also may be generated with the fusion images after acquisition from PET/CT in addition to the artifacts found in each of the separate modalities. It is essential for radiologists interpreting PET/CT to be aware of these artifacts and pitfalls and techniques to mitigate them. One such artifact is hot-clot sign, in which there is significant focal accumulation of FDG in the lung parenchyma in the absence of corresponding CT abnormalities and leads to false positive reporting. In this case series, we report five such cases with hot-clot artifact mimicking metastasis with different primary malignancy. Repeat study showed disappearance of such abnormal uptake in lung parenchyma.
CASE SERIES
Case 1
A 73-year-old male patient underwent 18F-FDG PET/CT scan for metastatic workup of moderately differentiated carcinoma of rectum. The study showed an intense hypermetabolic lung nodule located in posterior segment of the right upper lobe with SUVmax – 4.23. Corresponding CT images showed no structural abnormality [Figure 1]. A repeat 18F-FDG PET/ CT scan was performed after a brief interval of 10 days from the first study revealed no abnormal hypermetabolism in the previous intense focus of FDG activity.
Case 2
A 31-year-old lady patient underwent 18F-FDG PET/ CT scan for mediastinal lymph nodal mass with cervical lymphadenopathy in suspicion of a primary mass lesion. The study revealed conglomerate lymph nodes in cervical, axillary, and mediastinum with tiny focus of abnormal FDG uptake in the medial basal segment of the right lower lobe (SUVmax – 4.36) [Figure 2]. As there was no evidence of any pulmonary nodules in corresponding CT images, biopsy was deferred and a follow-up FDG PET/CT scan was done after a short interval of 5 days which showed complete resolution of the FDG focus in the right lower lobe [Figure 3].
Case 3
An 18-month-old baby came for 18F-FDG PET/CT with a biopsy proven spindle cell neoplasm in the ethmoid sinus. Scan showed a focal increased FDG uptake in lateral basal segment of the right lower lobe with SUVmax – 1.74 and no changes in the CT images [Figure 4]. An interval scan after 8 days revealed no abnormal FDG focus in lung parenchyma.
Case 4
A 51-year-old male patient underwent for 18F-FDG PET/CT scan for response assessment of stage IV carcinoma tongue after a course of chemoradiotherapy. The study revealed partial response to treatment with moderate reduction of the previous lesions and cervical lymphadenopathy. However, a hot focuses in the anterior segment of the left upper lobe [Figure 5] (SUVmax – 4.81) with no anatomical lung nodule correlation. Another scan performed after 7 days revealed no such hot spot in lung parenchyma.
Case 5
An old lady aged 72 years came for evaluation of anterior mediastinal mass with 18F-FDG PET/CT scan. Scan showed a lobulated FDG avid lobulated mass lesion in the anterior mediastinum along with enlarged hilar lymph nodes. Unusual small hot spot seen in the lateral basal segment of the right lower lobe with an SUVmax – 3.40 with no corresponding air space opacity/inflammatory changes on CT [Figure 6]. No focal lesions in repeat PET/CT scan after a short interval.
Table 1 shows summary of cases
Case list | Details | Findings | Artifact/Lesion |
---|---|---|---|
CASE 1 | 73-year-old patient for metastatic workup of moderately differentiated carcinoma of rectum | Hypermetabolic lung nodule located in posterior segment of the right upper lobe. | ARTIFACT |
CASE 2 | 31-year-old lady patient for mediastinal lymph nodal mass with cervical lymphadenopathy in suspicion of a primary mass lesion | Tiny focus of abnormal FDG uptake in the medial basal segment of the right lower lobe | ARTIFACT |
CASE 3 | 18-month-old baby came with a biopsy proven spindle cell neoplasm in the ethmoid sinus | Focal increased FDG uptake in lateral basal segment of the right lower lobe | ARTIFACT |
CASE 4 | 51-year-old male patient for response assessment of stage IV carcinoma tongue after a course of chemoradiotherapy | Hot focus in the anterior segment of the left upper lobe | ARTIFACT |
CASE 5 | 72-year-old lady came for evaluation of anterior mediastinal mass with 18F-FDG PET/CT scan | Lobulated FDG avid lobulated mass lesion in the anterior mediastinum along with enlarged hilar lymph nodes. Unusual small hot spot seen in the lateral basal segment of the right lower lobe | ARTIFACT |
DISCUSSION
18F-FDG uptake in lung parenchyma occurs due to various pathologies such as infection, inflammation, systemic diseases, primary lung carcinomas, and secondary metastatic lesions from different primary carcinomatous source, along with presence or absence of mediastinal lymphadenopathy which is associated with definitive structural findings on CT. Under rare occurrences, focal area of tracer accumulation is evident in lung parenchyma without corresponding structural abnormalities which are called as hot-clot sign/artifact. This can be attributed to two main reasons – it can either be due to an inflammatory vascular microthrombus or due to iatrogenic microembolism caused by faulty radiotracer injection technique.
Pathophysiology of the micro-embolism is active thrombus formation at the site of vascular injury or during aspiration of blood into the needle hub prior to radio-tracer injection. Higher affinity of activated platelets to FDG consequently agglutinates FDG to microthrombus. Microembolus, then, gets lodged in the distal capillary lung bed in the lung parenchyma and creates a focus of FDG uptake without corresponding parenchymal lesions/structural abnormality on CT images. To minimize this artifact, a secure intravenous line access is required to prevent paravenous/high-speed handheld injection and to avoid aspiration into the needle hub. Flushing of intravenous access is also necessary before injecting radiotracer to the patient.[2,3]
A misalignment between PET and CT image planes can be another reason for mismatching. Lungs frequently display the misalignment due to inappropriate breath control of PET and CT images during scan. Shallow breathing helps achieve an optimal image fusion during the PET/CT acquisition.[4]
Diagnosis of hot-clot artifact is based on three important factors: first, a focal or multiple intense FDG uptake spots without any structural CT abnormality, second, it should be located in the peripheral aspect independent to other lesions (if any) without any coinciding CT findings, and finally, disappearance of the focal intense metabolic activity on rescanning.[5]
Understanding about the hot-clot artifact which is specific to PET/CT is scarce. Karantanis et al. proved that intense FDG foci progresses to more peripheral location on repeated scan which is performed after 30 min from the initial scan, thus excluding any actual parenchymal lung abnormality.[6] \Ha et al. reported three cases of Hot-clot artifact, in which a single patient had five such hot spots which showed complete resolution on repeat scan.[7] Few other literatures also proved that rescanning at later date (few days to few weeks) helps eliminating the artifact from real metastatic lesions.[8,9]
CONCLUSION
Awareness about hot-clot sign/artifacts prevents misdiagnosing which leads to erroneous upstaging of tumor causing mismanagement of oncological patients. Therefore, mindfulness about proper injection techniques with indwelling intravenous cannula and avoiding aspiration into the needle hub can prevent micro-embolism helps reducing false reporting and mismanagement. Follow-up scan is preferred to differentiate artifacts from parenchymal lesions.
TEACHING POINTS
Proper injection technique with indwelling intravenous catheter can prevent this artifact.
Follow-up scan differentiates hot-clot artifact from real parenchymal lesions.
MCQs
-
What type of artifact is Hot-clot artifact?
Patient related
Instrument related
Radiotracer related
Answer Key: c
-
What is the interval time to differentiate the hot-clot from a real parenchymal lesion?
Repeat scan immediately after the 1st scan
After few days or weeks
Repeat within 48 h of the 1st scan
Answer Key: b
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent.
Conflicts of interest
There are no conflicts of interest.
Financial support and sponsorship
Nil.
References
- Hot-clot artifact in the lung parenchyma on 18F-fluorodeoxyglucose positron emission tomography/computed tomography mimicking malignancy with a homolateral non-small cell lung cancer. World J Nucl Med. 2021;20:202-4.
- [CrossRef] [PubMed] [Google Scholar]
- Hot-clot artifacts in the lung parenchyma on F-18 fluorodeoxyglucose positron emission tomography/CT due to faulty injection techniques: Two case reports. Korean J Radiol. 2014;15:530-3.
- [CrossRef] [PubMed] [Google Scholar]
- Optimal CT breathing protocol for combined thoracic PET/CT. AJR Am J Roentgenol. 2006;187:1357-60.
- [CrossRef] [PubMed] [Google Scholar]
- Pearls and Pitfalls in Thoracic Imaging: Variants and other Difficult Diagnoses. New York: Cambridge University Press; 2011:198-201.
- [CrossRef] [Google Scholar]
- Focal F-18 fluoro-deoxy-glucose accumulation in the lung parenchyma in the absence of CT abnormality in PET/CT. J Comput Assist Tomogr. 2007;31:800-5.
- [CrossRef] [PubMed] [Google Scholar]
- Incidental focal F-18 FDG accumulation in lung parenchyma without abnormal CT findings. Ann Nucl Med. 2009;23:599-603.
- [CrossRef] [PubMed] [Google Scholar]
- 18F-FDG PET/CT lung 'focalities' without coregistered CT findings: An interpretative clinical dilemma. Nucl Med Commun. 2015;36:334-9.
- [CrossRef] [PubMed] [Google Scholar]
- Focal FDG uptake in lung parenchyma without structural alterations on CT. World J Nucl Med. 2013;12:38-40.
- [CrossRef] [PubMed] [Google Scholar]